UNSPSC 51162723: Guaiacol phosphate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C21H21O7P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56492O1F0U, chemically known as phenol, 2-methoxy-, phosphate (3:1), but more generally known as guaiacol phosphate, which bears US NIH Compound Identifier 68420. European Medicines Agency schedules guaiacol phosphate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG.

Most nations, for tariff purposes, schedule guaiacol phosphate under HS 29095000. SMILES: COC1CCCCC1OP(=O)(OC2CCCCC2OC)OC3CCCCC3OC.

UNSPSC 51162723 Guaiacol phosphate is a Commodity code, but the recent state and local opportunities tagged under it involve pharmaceutical products and drug-related supplies that fall outside the code's nominal chemical scope — naloxone procurement and multi-source generic pharmaceuticals through cooperative purchasing. The mismatch suggests the code shows little relevant recent activity aligned with its stated product definition.

The two posted opportunities involve naloxone and safe drug deactivation systems for Seminole County, Florida (IFB posted June 30, 2026, response due July 26, 2023) and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026). Neither opportunity directly targets guaiacol phosphate or chemically equivalent products. Procurement activity under this code does not reflect concentration in a single jurisdiction or repeat buyer pattern. No budget values or set-aside designations are disclosed in the available opportunity records.